These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25584812)

  • 1. Rates of False-Positive Classification Resulting From the Analysis of Additional Embedded Performance Validity Measures.
    Silk-Eglit GM; Stenclik JH; Miele AS; Lynch JK; McCaffrey RJ
    Appl Neuropsychol Adult; 2015; 22(5):335-47. PubMed ID: 25584812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance Validity Classification Accuracy of Single-, Pairwise-, and Triple-Failure Models Using the Halstead-Reitan Neuropsychological Battery for Adults.
    Silk-Eglit GM; Stenclik JH; Miele AS; Lynch JK; McCaffrey RJ
    Appl Neuropsychol Adult; 2015; 22(4):271-81. PubMed ID: 25402434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive rates associated with the use of multiple performance and symptom validity tests.
    Larrabee GJ
    Arch Clin Neuropsychol; 2014 Jun; 29(4):364-73. PubMed ID: 24769887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregating validity indicators: The salience of domain specificity and the indeterminate range in multivariate models of performance validity assessment.
    Erdodi LA
    Appl Neuropsychol Adult; 2019; 26(2):155-172. PubMed ID: 29111772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the classification accuracy of multiple performance validity tests in a mixed clinical sample.
    Messerly J; Soble JR; Webber TA; Alverson WA; Fullen C; Kraemer LD; Marceaux JC
    Appl Neuropsychol Adult; 2021; 28(6):727-736. PubMed ID: 31835915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-validation of three Advanced Clinical Solutions performance validity tests: Examining combinations of measures to maximize classification of invalid performance.
    Bain KM; Soble JR; Webber TA; Messerly JM; Bailey KC; Kirton JW; McCoy KJM
    Appl Neuropsychol Adult; 2021; 28(1):24-34. PubMed ID: 30987451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five shades of gray: Conceptual and methodological issues around multivariate models of performance validity.
    Erdodi LA
    NeuroRehabilitation; 2021; 49(2):179-213. PubMed ID: 34420986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative false positive rates given multiple performance validity tests: commentary on Davis and Millis (2014) and Larrabee (2014).
    Bilder RM; Sugar CA; Hellemann GS
    Clin Neuropsychol; 2014; 28(8):1212-23. PubMed ID: 25490983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing false positive error with multiple performance validity tests: response to Bilder, Sugar, and Hellemann (2014 this issue).
    Larrabee GJ
    Clin Neuropsychol; 2014; 28(8):1230-42. PubMed ID: 25491180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs.
    An KY; Kaploun K; Erdodi LA; Abeare CA
    Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further examination of embedded performance validity indicators for the Conners' Continuous Performance Test and Brief Test of Attention in a large outpatient clinical sample.
    Sharland MJ; Waring SC; Johnson BP; Taran AM; Rusin TA; Pattock AM; Palcher JA
    Clin Neuropsychol; 2018 Jan; 32(1):98-108. PubMed ID: 28548557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVLT-II Forced Choice Recognition Trial as an Embedded Validity Indicator: A Systematic Review of the Evidence.
    Schwartz ES; Erdodi L; Rodriguez N; Ghosh JJ; Curtain JR; Flashman LA; Roth RM
    J Int Neuropsychol Soc; 2016 Sep; 22(8):851-8. PubMed ID: 27619108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64.
    Reslan S; Axelrod BN
    Appl Neuropsychol Adult; 2017; 24(2):132-139. PubMed ID: 27045467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity issues in Atkins death cases.
    Chafetz MD; Biondolillo A
    Clin Neuropsychol; 2012; 26(8):1358-76. PubMed ID: 23035759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embedded measures of performance validity using verbal fluency tests in a clinical sample.
    Sugarman MA; Axelrod BN
    Appl Neuropsychol Adult; 2015; 22(2):141-6. PubMed ID: 25153155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to commentary by Bilder, Sugar, and Helleman (2014 this issue) on minimizing false positive error with multiple performance validity tests.
    Davis JJ; Millis SR
    Clin Neuropsychol; 2014; 28(8):1224-9. PubMed ID: 25491099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered.
    Davis JJ
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1013-1021. PubMed ID: 29779432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of malingering detection measures for attention-deficit/hyperactivity disorder.
    Wallace ER; Garcia-Willingham NE; Walls BD; Bosch CM; Balthrop KC; Berry DTR
    Psychol Assess; 2019 Feb; 31(2):265-270. PubMed ID: 30359048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating constructs represented by symptom validity tests in forensic neuropsychological assessment of traumatic brain injury.
    Frederick RI; Bowden SC
    J Head Trauma Rehabil; 2009; 24(2):105-22. PubMed ID: 19333066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.